Xylem Balance Sheet Health
Financial Health criteria checks 6/6
Xylem has a total shareholder equity of $10.3B and total debt of $2.0B, which brings its debt-to-equity ratio to 19.3%. Its total assets and total liabilities are $15.8B and $5.4B respectively. Xylem's EBIT is $1.1B making its interest coverage ratio 42.4. It has cash and short-term investments of $815.0M.
Key information
19.3%
Debt to equity ratio
US$2.00b
Debt
Interest coverage ratio | 42.4x |
Cash | US$815.00m |
Equity | US$10.35b |
Total liabilities | US$5.42b |
Total assets | US$15.77b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XYL's short term assets ($3.8B) exceed its short term liabilities ($2.0B).
Long Term Liabilities: XYL's short term assets ($3.8B) exceed its long term liabilities ($3.4B).
Debt to Equity History and Analysis
Debt Level: XYL's net debt to equity ratio (11.4%) is considered satisfactory.
Reducing Debt: XYL's debt to equity ratio has reduced from 84.4% to 19.3% over the past 5 years.
Debt Coverage: XYL's debt is well covered by operating cash flow (60.3%).
Interest Coverage: XYL's interest payments on its debt are well covered by EBIT (42.4x coverage).